AcceLINX is a multi-stage accelerator. We don’t focus on just one stage of business evolution; we support selected companies whose founders just have a sketch on a napkin all the way to companies with products in the market and early revenues. We also have a concentration in musculoskeletal health. We aren’t trying to be all things to all people. We want to leverage the immense strengths in these fields that can be found here in the region.

Our primary focus is where we have domain expertise in the region, which is in the areas of musculoskeletal health, primarily orthopedics, spine and biologics. That doesn’t necessarily limit us to physical devices; we’re interested in everything from lab to bedside that contributes to improving patient care and cost effectiveness in musculoskeletal health.

While they are members of OrthoWorx, which led the development of AcceLINX, and they are supportive of this initiative, they will not have a direct role in AcceLINX. It is reasonable to expect that they may be interested in some of the technologies that are developed by AcceLINX-supported start-ups if they fit with their strategic plans.

No. This isn’t like a 90-day boot camp where you enter on day one and leave on day 90. AcceLINX was founded to support companies all the way through to an exit, which takes an average of seven years in our industry. We can support companies at any stage of their evolution.

No. Every company is faced with its own set of challenges, and the AcceLINX team works with qualified applicants to determine the best path forward.